ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 28 Jun 2021
Last Applicant/ Owned by
87 Cambridge Park Drive
Cambridge
MA
02140
Serial Number
88918443 filed on 15th May 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ZILBRYSQ ZILUCOPLAN
Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutica Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents, all of the foregoing containing Zilucoplan
Class [010]
Medical Instrument Products
Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication
Mark Details
Serial Number
No 88918443
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 2011.2004TM
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Jun 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 28th Jun 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 24th Nov 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 29th Sep 2020 | PUBLISHED FOR OPPOSITION |
| 29th Sep 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 09th Sep 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 08th Sep 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 01st Sep 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 01st Sep 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 01st Sep 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |